A Mason-Pfizer Monkey virus Gag-GFP fusion vector allows visualization of capsid transport in live cells and demonstrates a role for microtubules. by Jasmine Clark, Petra Grznarova, Elizabeth Stansell, William Diehl, Jan Lipov, Paul Spearman, Tomas Ruml, Eric Hunter

“…Immature capsids of the Betaretrovirus, Mason-Pfizer Monkey virus (M-PMV), are assembled in the pericentriolar region of the cell, and are then transported to the plasma membrane for budding. …”
Get full text

A predictive model to estimate fever after receipt of the second dose of Pfizer‐BioNTech coronavirus disease 2019 vaccine: An observational cohort study by Satoru Chiba, Kaoru Shinohara

“…A total of 153 medical personnel aged 22–86 years of age were involved in the study to receive two doses, intramuscularly 21 days apart, of the Pfizer‐BioNTech COVID‐19 vaccine (30 μg per dose). …”
Get full text

Multisystem inflammatory syndrome in a male adolescent after his second Pfizer-BioNTech COVID-19 vaccine: a report from Turkey by Hayrullah Alp, Melih Timuçin Doğan

“…We present details on a 15-year-old previously healthy Turkish male adolescent who fulfilled the diagnostic criteria for MIS-C after the Pfizer-BioNTech vaccine.…”
Get full text

Effect of Pfizer/BioNTech and Sinovac/CoronaVac Vaccines on Semen Parameters in Infertile Patients with Idiopathic Infertility: A Single-center Cohort Study by Eyüp Dil

Subjects: Get full text

Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database by Mansour Tobaiqy, Katie MacLure, Hajer Elkout, Derek Stewart

Subjects: Get full text

Total anti-SARS-CoV-2 antibodies measured 6 months after Pfizer-BioNTech COVID-19 vaccination in healthcare workers by Salvagno Gian Luca, Henry Brandon M., Pighi Laura, de Nitto Simone, Lippi Giuseppe

“…Background: This study aimed at monitoring the kinetics of serum total anti-SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) antibodies in a cohort of healthcare workers after voluntary vaccination with Pfizer-BioNTech coronavirus disease 2019 (COVID-19) mRNA-based vaccine. …”
Get full text

Kinetics of the Neutralizing and Spike SARS-CoV-2 Antibodies following the Sinovac Inactivated Virus Vaccine Compared to the Pfizer mRNA Vaccine in Singapore by Chin Shern Lau, May Lin Helen Oh, Soon Kieng Phua, Ya Li Liang, Yanfeng Li, Jianxin Huo, Yuhan Huang, Biyan Zhang, Shengli Xu, Tar Choon Aw

“…Methods: We studied 96 Pfizer and 34 Sinovac vaccinees over a 14-month period from January 2021 to February 2022. …”
Get full text

Hypereosinophilic Syndrome Following the BNT162b2 (BioNTech/Pfizer) Vaccine Successfully Treated with Mepolizumab: A Case Report and Review of the Literature by Ariela Hoxha, Tania Tomaselli, Giacomo Maria Minicucci, Jacopo Dall’Acqua, Davide Zardo, Paolo Simioni, Luigi Naldi

“…Here, we report a full-blown hypereosinophilic syndrome (HES) following a BNT162b2 (BioNTech/Pfizer) vaccine. A 48-year-old man developed, 5 days after the first shot of the SARS-CoV-2 vaccine, erythematous and painful nodular lesions in the lower and upper limbs accompanied by widespread itching, acrocyanosis with gangrenous lesions at the tips of the first and fourth fingers of the right hand, as well as paresthesia in the right hand and foot. …”
Get full text

A Case of Acquired Aplastic Anemia after Severe Hepatitis- Probably Induced by the Pfizer/BioNTech Vaccine: A Case Report and Review of Literature by Zahra Kmira, Khirallah Sabrine, Guermazi Monia, Akkari Imen, Chiba Dorra, Bannour Rania, Fathallah Neila, Bouteraa Walid, Zaier Monia, Ben Youssef Yosra, Regaieg Haifa, Khelif Abderrahim

Subjects: Get full text

HLA-A∗03:01 is associated with increased risk of fever, chills, and stronger side effects from Pfizer-BioNTech COVID-19 vaccination by Alexandre Bolze, Iva Neveux, Kelly M. Schiabor Barrett, Simon White, Magnus Isaksson, Shaun Dabe, William Lee, Joseph J. Grzymski, Nicole L. Washington, Elizabeth T. Cirulli

“…In Pfizer-BioNTech recipients, HLA-A∗03:01 was associated with a 2-fold increase in risk of self-reported severe difficulties with daily routine following vaccination. …”
Get full text

The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence by Luis Rosero-Bixby

“…The intervention retrospectively evaluated is vaccination with Pfizer-BioNTech (78%) and Oxford-AstraZeneca (22%). …”
Get full text

Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies by Megan Wallace, Jennifer P. Collins, Heidi Moline, Ian D. Plumb, Monica Godfrey, Rebecca L. Morgan, Doug Campos-Outcalt, Sara E. Oliver, Kathleen Dooling, Julia W. Gargano

“…In December 2020, an interim recommendation for the use of Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years was made under Food and Drug Administration’s Emergency Use Authorization. …”
Get full text

Comparing the longer-term effectiveness of a single dose of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines across the age spectrum by Amit Kaura, Adam Trickey, Anoop S V Shah, Umberto Benedetto, Ben Glampson, Abdulrahim Mulla, Luca Mercuri, Sanjay Gautama, Ceire E Costelloe, Ian Goodman, Julian Redhead, Kavitha Saravanakumar, Erik Mayer, Jamil Mayet

“…We compared the effectiveness of a single dose strategy of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines against SARS-CoV-2 infection across all age groups and over an extended follow-up period. …”
Get full text

De Novo Minimal Change Disease following Vaccination with the Pfizer/BioNTech SARS-CoV-2 Vaccine in a Living Kidney Donor by Smaragdi Marinaki, Kyriaki Kolovou, George Liapis, Chrysanthi Skalioti, Stathis Tsiakas, Ioannis Boletis

“…We report on a case of a kidney donor, who developed minimal change disease (MCD) within 4 days post-vaccination with the SARS-CoV-2 BNT162b2 mRNA vaccine (Pfizer/BioNTech). She donated her kidney to her husband 4 years ago. …”
Get full text

Pengembangan model Collaborative Planning Forecasting and Replenishment (CPFR) berdasar evaluasi Inventory dalam Supply Chain Management di Pfizer Consumer Healthcare Indonesia by , HENDARTI, Titiek Sri, , Adi Joko Guritno, Dr.,Ir.,MSIE

A rare presentation of undiagnosed multiple sclerosis after the COVID-19 vaccine by Ariana R. Tagliaferri, George Horani, Katherine Stephens, Patrick Michael

Subjects: Get full text

Text Mining and Determinants of Sentiments towards the COVID-19 Vaccine Booster of Twitter Users in Malaysia by Song-Quan Ong, Maisarah Binti Mohamed Pauzi, Keng Hoon Gan

Subjects: Get full text

Immune thrombocytopenia relapse post covid-19 vaccine in young male patient by Hana Qasim, Elrazi Ali, Mohamad A. Yassin

Subjects: Get full text

Rhabdomyolysis after COVID-19 Comirnaty Vaccination: A Case Report by Veerle J. Ruijters, Marjon F.G. van der Meulen, Michael A. van Es, Tessa Smit, Jessica E. Hoogendijk

Subjects: Get full text

Fulminant Giant Cell Myocarditis following Heterologous Vaccination of ChAdOx1 nCoV-19 and Pfizer-BioNTech COVID-19 by Dong-Hoon Kang, Joo-Young Na, Jun-Ho Yang, Seong-Ho Moon, Sung-Hwan Kim, Jae-Jun Jung, Ho-Jeong Cha, Jong-Hwa Ahn, Yong-Whi Park, Sang-Yeong Cho, Ho-Kyung Yu, Soo-Hee Lee, Mi-Yeong Park, Jong-Woo Kim, Joung-Hun Byun

“…A 48-year-old female patient underwent a heart transplantation for acute fulminant myocarditis, following heterologous vaccination with the ChAdOx1 nCoV-19 and Pfizer-BioNTech COVID-19. She had no history of severe acute respiratory syndrome coronavirus-2 infection. …”
Get full text